Assyro AI

FDA Orange Book · active-ingredient family

Tropicamide

Tropicamide is approved as 1 brand and 14 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:MYDRIACYL · NDA 012111

1

Brand (NDA)

14

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution/drops

ProductApplicantApplicationTEApproved
MYDRIACYL×2ALCONNDA 012111Approved Prior to Jan 1, 1982

Generic (ANDA) products (14)

ProductApplicantApplicationTEApproved
TROPICAMIDESOMERSET THERAPS LLCANDA 207524ATDec 12, 2019
TROPICACYLEPIC PHARMA LLCANDA 040314ATSep 29, 2000
TROPICACYLRISINGANDA 040315ATSep 29, 2000
TROPICAMIDEBAUSCH AND LOMBANDA 040067ATJul 27, 1994
TROPICAMIDEBAUSCH AND LOMBANDA 040064ATJul 27, 1994
TROPICAMIDEALCON PHARMS LTDANDA 089172Dec 28, 1990
TROPICAMIDEWATSON LABSANDA 089171Dec 28, 1990
TROPICAMIDEEPIC PHARMA LLCANDA 088447Aug 28, 1985
MYDRIAFAIRPHARMAFAIRANDA 088274Sep 16, 1983
MYDRIAFAIRPHARMAFAIRANDA 088230Sep 16, 1983
TROPICAMIDEMIZA PHARMS USAANDA 087637Aug 09, 1982
TROPICAMIDEMIZA PHARMS USAANDA 087636Jul 30, 1982
MYDRIACYLRLDALCON LABS INCANDA 084306ATApproved Prior to Jan 1, 1982
MYDRIACYLRLDSANDOZANDA 084305ATApproved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Tropicamide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.